Vimarsana
Biggest News Aggregation in the World

Page 4 - Skye Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Skye Bioscience Today - Breaking & Trending Today

Top 10 Whistleblowing and Retaliation Events of 2023 | Proskauer Rose LLP - Vimarsana News

Top 10 Whistleblowing and Retaliation Events of 2023 | Proskauer Rose LLP

2023 was another groundbreaking year for whistleblower litigation and bounty awards. The U.S. Securities and Exchange Commission shattered records by issuing a $279...

Glaucoma Treatment Market Set to Surge at 4.3% CAGR, to - Vimarsana News

Glaucoma Treatment Market Set to Surge at 4.3% CAGR, to

Increasing research and innovation in various treatment options will drive demand for glaucoma treatment....

Skye Bioscience, Inc. (OTCMKTS:SKYE) Sees Significant Increase in Short Interest - Vimarsana News

Skye Bioscience, Inc. (OTCMKTS:SKYE) Sees Significant Increase in Short Interest

Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 1,300 shares, an increase of 1,200.0% from the November 15th total of 100 shares. Based on an average daily volume of 7,400 shares, […]

Global Cannabis Odyssey: Ontario Expansion, Australian Exports And Innovations In Africa - Vimarsana News

Global Cannabis Odyssey: Ontario Expansion, Australian Exports And Innovations In Africa

Embark on a global cannabis expedition: Ontario doubles its store count, Australia sees a rise in exports, and a novel partnership that targets medical cannabis development in Africa.

Skye Bioscience Responds to OTC Markets Promotional Policy - Vimarsana News

Skye Bioscience Responds to OTC Markets Promotional Policy

Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, focusing on metabolic conditions and glaucoma, has received a request by OTC Markets Group Inc....